Your browser doesn't support javascript.
loading
Retention rate of a second line with a biologic DMARD after failure of a first-line therapy with abatacept, tocilizumab, or rituximab: results from the Italian GISEA registry.
Sebastiani, Marco; Venerito, Vincenzo; Bugatti, Serena; Bazzani, Chiara; Biggioggero, Martina; Petricca, Luca; Foti, Rosario; Bortoluzzi, Alessandra; Balduzzi, Silvia; Visalli, Elisa; Frediani, Bruno; Manfredi, Andreina; Gremese, Elisa; Favalli, Ennio; Iannone, Florenzo; Ferraccioli, Gianfranco; Lapadula, Giovanni.
Afiliação
  • Sebastiani M; Rheumatology Unit, University of Modena and Reggio Emilia, Azienda Ospedaliero-Universitaria Policlinico di Modena, Via del Pozzo, 41125, Modena, Italy. marco.sebastiani@unimore.it.
  • Venerito V; Department of Emergency and Organ Transplantation, Rheumatology Unit, University of Bari, Bari, Italy.
  • Bugatti S; Division of Rheumatology, IRCCS Policlinico San Matteo Foundation, University of Pavia, Pavia, Italy.
  • Bazzani C; Unit of Rheumatology and Clinical Immunology, ASST Spedali Civili, Brescia, Italy.
  • Biggioggero M; Department of Rheumatology, Gaetano Pini Institute, Milan, Italy.
  • Petricca L; Division of Rheumatology, Catholic University of the Sacred Heart, Rome, Italy.
  • Foti R; Rheumatology Unit, A.O.U. Policlinico San Marco, Catania, Italy.
  • Bortoluzzi A; Section of Rheumatology, Department of Medical Sciences, University of Ferrara and Azienda Ospedaliera-Universitaria di Ferrara, Ferrara, Italy.
  • Balduzzi S; Division of Rheumatology, IRCCS Policlinico San Matteo Foundation, University of Pavia, Pavia, Italy.
  • Visalli E; Rheumatology Unit, A.O.U. Policlinico San Marco, Catania, Italy.
  • Frediani B; Rheumatology Unit, Department of Medical Sciences, Surgery e Neurosciences, University of Siena, Siena, Italy.
  • Manfredi A; Rheumatology Unit, University of Modena and Reggio Emilia, Azienda Ospedaliero-Universitaria Policlinico di Modena, Via del Pozzo, 41125, Modena, Italy.
  • Gremese E; Division of Rheumatology, Catholic University of the Sacred Heart, Rome, Italy.
  • Favalli E; Department of Rheumatology, Gaetano Pini Institute, Milan, Italy.
  • Iannone F; Department of Emergency and Organ Transplantation, Rheumatology Unit, University of Bari, Bari, Italy.
  • Ferraccioli G; Division of Rheumatology, Catholic University of the Sacred Heart, Rome, Italy.
  • Lapadula G; Department of Emergency and Organ Transplantation, Rheumatology Unit, University of Bari, Bari, Italy.
Clin Rheumatol ; 40(10): 4039-4047, 2021 Oct.
Article em En | MEDLINE | ID: mdl-33881676
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Produtos Biológicos / Antirreumáticos Tipo de estudo: Guideline / Prognostic_studies Limite: Humans País como assunto: Europa Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Produtos Biológicos / Antirreumáticos Tipo de estudo: Guideline / Prognostic_studies Limite: Humans País como assunto: Europa Idioma: En Ano de publicação: 2021 Tipo de documento: Article